These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24044638)

  • 1. Effect of P-glycoprotein on the rat intestinal permeability and metabolism of the BDDCS class 1 drug verapamil.
    Estudante M; Maya M; Morais JG; Soveral G; Benet LZ
    Mol Pharm; 2013 Nov; 10(11):4038-45. PubMed ID: 24044638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.
    Johnson BM; Charman WN; Porter CJ
    Drug Metab Dispos; 2003 Sep; 31(9):1151-60. PubMed ID: 12920171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
    Johnson BM; Charman WN; Porter CJ
    AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
    Zheng Y; Benet LZ; Okochi H; Chen X
    Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL; Salphati L; Reid MJ; Benet LZ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.
    Choi DH; Shin WG; Choi JS
    Eur J Clin Pharmacol; 2008 May; 64(5):445-9. PubMed ID: 18193210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic evaluation of the absorption, efflux, and metabolism of verapamil in the autoperfused rat jejunum.
    Johnson BM; Chen W; Borchardt RT; Charman WN; Porter CJ
    J Pharmacol Exp Ther; 2003 Apr; 305(1):151-8. PubMed ID: 12649363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.
    Neuhoff S; Yeo KR; Barter Z; Jamei M; Turner DB; Rostami-Hodjegan A
    J Pharm Sci; 2013 Sep; 102(9):3161-73. PubMed ID: 23686764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents.
    Woodland C; Koren G; Wainer IW; Batist G; Ito S
    Can J Physiol Pharmacol; 2003 Aug; 81(8):800-5. PubMed ID: 12897809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats.
    Sandström R; Lennernäs H
    Drug Metab Dispos; 1999 Aug; 27(8):951-5. PubMed ID: 10421625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug interaction studies in preclinical species: should metabolite(s) kinetics be studied?
    Srinivas NR
    Xenobiotica; 2009 Mar; 39(3):193-6. PubMed ID: 19280517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A; Alves G; Falcão A; Soares-da-Silva P
    Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
    Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
    Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions.
    Zhang J; Zhou F; Wu X; Gu Y; Ai H; Zheng Y; Li Y; Zhang X; Hao G; Sun J; Peng Y; Wang G
    Drug Metab Dispos; 2010 Dec; 38(12):2179-87. PubMed ID: 20837659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexity of intestinal absorption and exsorption of digoxin in rats.
    Yao HM; Chiou WL
    Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.